Skip to content

A Comparative Study of GPI's DBS and Pallidotomy in the Treatment of Meige Syndrome

A Comparative Study of GPI's DBS and Pallidotomy in the Treatment of Meige Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04618887
Enrollment
100
Registered
2020-11-06
Start date
2020-01-01
Completion date
2023-12-31
Last updated
2020-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blepharospasm, Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid, Blepharospasm of Right Eyelid, Blepharospasm Oromandibular Dystonia, Meige Disease, Meige Syndrome, Meigs Syndrome, Meig Syndrome

Keywords

deep brain stimulation, DBS, DBNL, GPi, pallidotomy

Brief summary

In this study, we will compare the degree of postoperative symptom improvement, postoperative complication rate, postoperative quality of life improvement degree of patients with Meige syndrome undergoing pallidotomy (unilateral globus palliotomy) and deep brain stimulation (unilateral globus pallidus) ,in order to get the conclusion of the comparison of the clinical efficacy of the two surgical plans. In addition, possible predictive factors such as age, gender, age of onset, length of disease course, scale baseline score, preoperative brain PET-CT function analysis and other possible predictive factors are added for analysis, in order to find predictive factors that can guide the choice of surgical options.

Interventions

PROCEDUREpallidotomy

deep brain nuclei lesion of GPi

PROCEDUREdeep brain stimulation

deep brain stimulation of GPi

Sponsors

Peking University People's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients confirmed Meige sydrome

Exclusion criteria

* Patients who cannot finish the neurosurgery or the postoperative evaluation

Design outcomes

Primary

MeasureTime frameDescription
Symptom2 yearsspasm of eyelid
complications2 yearsPostoperative complications

Secondary

MeasureTime frameDescription
quality of life2 yearsEvaluate using SF-36
depression scale2 yearsEvaluate using Hamilton Depression Scale

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026